Euronext Brussels

Belgian indices

BEL 20 5,006.48 +0.41 %
BEL ALL-SHARE 15,891.79 +0.49 %
BEL MID INDEX 6,367.11 +0.12 %
BEL SMALL INDEX 8,229.28 +0.30 %
BEL CONTINUOUS 42,037.32 +0.49 %

EU indices

EURONEXT 100 1,706.29 +0.69 %
CLIMATE EUROPE 2,174.16 +0.76 %
LOW CARBON 100 168.79 +1.02 %
NEXT BIOTECH 4,134.41 -3.55 %
ESG 80 2,211.19 +0.75 %

Currency rates - Last and change

EUR / USD 1.17494 -0.02 %
EUR / GBP 0.87902 +0.05 %
EUR / JPY 182.189 -0.13 %
EUR / CHF 0.93555 +0.01 %
GBP / USD 1.33663 -0.08 %

Top performers Brussels

Loading... Please wait.
Belgian indices
BEL 20
Chart
BEL ALL-SHARE
Chart
BEL CONTINUOUS
Chart
BEL MID INDEX
Chart
BEL SMALL INDEX
Chart
Company news
15 Dec 2025
18:11 CET
GBL - Transacties op GBL-aandelen 15-12-2025
15 Dec 2025
18:10 CET
GBL - Transactions sur actions propres 15-12-2025
15 Dec 2025
18:09 CET
GBL - Transactions on GBL shares 15-12-2025
15 Dec 2025
18:07 CET
Publication of a transparency notification
15 Dec 2025
18:06 CET
Publication d’une notification de transparence
15 Dec 2025
18:06 CET
Openbaarmaking van een transparantiekennisgeving
15 Dec 2025
17:45 CET
Notification de participation par UBS Group AG
15 Dec 2025
17:45 CET
Participation notification by UBS Group AG
15 Dec 2025
17:45 CET
Melexis: update over het aandeleninkoopprogramma
15 Dec 2025
17:45 CET
Participatiemelding van UBS Group AG
15 Dec 2025
17:45 CET
Melexis: update on the share buy-back program
15 Dec 2025
17:40 CET
DEME wins contract to help restore water quality in the central Netherlands
15 Dec 2025
17:40 CET
DEME wint contract voor herstel van waterkwaliteit in Midden-Nederland
15 Dec 2025
07:58 CET
Publication du nouveau dénominateur après l'augmentation de capital de Care Property Invest
15 Dec 2025
07:58 CET
Disclosure new denominator after Care Property Invest's capital increase
15 Dec 2025
07:56 CET
Openbaarmaking nieuwe noemer na de kapitaalverhoging van Care Property Invest
15 Dec 2025
07:00 CET
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer
15 Dec 2025
07:00 CET
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
15 Dec 2025
07:00 CET
La protonthérapie, nouvelle norme de soins pour les patients atteints d'un cancer de l'oropharynx
15 Dec 2025
06:57 CET
Inkoop eigen aandelen, wekelijkse update
IPOs
MATERIALISE
ADEC INNOVATIONS
ENERGYVISION
SYENSQO
DMS IMAGING
More Euronext Brussels

Learn more about our Brussels markets

Visit our Brussels page on Euronext.com and learn about the home to the BEL20. 

Euronext Brussels - Le Marquis